JUSTIN LEWIS: Open Payments
NPI 1538696356 · SALEM, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 16 payments from 9 companies in 2025. Trend: 2023 $186 · 2024 $474 · 2025 $357
Food & beverage: $357
| Company | Payments | Amount |
|---|---|---|
| Lucid Diagnostics Inc. | 3 | $78 |
| Supernus Pharmaceuticals, Inc. | 4 | $65 |
| E.R. Squibb & Sons, L.L.C. | 2 | $64 |
| Phathom Pharmaceuticals, Inc. | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
| Averitas Pharma Inc. | 1 | $26 |
| Phadia US Inc. | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
Products named: Qelbree, COBENFY, VOQUEZNA, CAPLYTA, REXULTI, QUTENZA, ImmunoCAP, HETLIOZ.
Industry payments across KY — which companies pay providers there.
